Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock is traded on the NASDAQ Capital Market (“NASDAQ”) under the symbol “BWEN.” The following table sets forth the high and low bid prices of our common stock traded on the NASDAQ.
Common Stock
High
Low
2025
First quarter
$
2.21
$
1.41
Second quarter
1.96
1.47
Third quarter
2.87
1.80
Fourth quarter
3.55
2.00
Common Stock
High
Low
2024
First quarter
$
2.70
$
2.22
Second quarter
4.42
2.08
Third quarter
3.66
2.07
Fourth quarter
2.23
1.55
The closing price for our common stock as of March 4, 2026 was $2.47. As of March 4, 2026, there were 48 holders of record of our common stock.
Dividends
We have never paid cash dividends on our common stock and have no current plan to do so in the foreseeable future. The declaration and payment of dividends on our common stock are subject to the discretion of our Board and are further limited by our credit agreement and other contractual agreements we may have in place from time to time. The decision of our Board to pay future dividends will depend on general business conditions, the effect of a dividend payment on our financial condition, and other factors our Board may consider relevant. The current policy of our Board is to reinvest cash generated in our operations to promote future growth and to fund potential investments.
Repurchases
On September 10, 2025, our Board authorized a program to repurchase up to $3,000 of our outstanding common stock. Our share repurchase program does not obligate us to acquire any specific number of shares. The common stock may be acquired in the open market at prices subject to certain pricing guidelines determined by management. We have no obligation to repurchase shares and we may discontinue purchases at any time that we determine additional purchases are not warranted. As of December 31, 2025, $3,000 remains available for repurchase and there were no stock repurchases during the years ended December 31, 2025 and 2024.
Unregistered Sales of Equity Securities
There were no unregistered sales of equity securities during the years ended December 31, 2025 and 2024.
Securities Authorized for Issuance Under Equity Compensation Plans
See Part III, Item 12 “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” of this Annual Report on Form 10-K for information as of December 31, 2025 with respect to shares of our common stock that may be issued under our existing share-based compensation plans.
21
ITEM 6. SELECTED FINANCIAL DATA
[RESERVED]